Mahmod, A., Essa, S., Abdel Aal, E., Dawod, H. (2012). Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2(2), 87-91. doi: 10.21608/aeji.2012.15955
Ahmad Mahmod; Samy Essa; Eman Abdel Aal; Hosam Dawod. "Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis". Afro-Egyptian Journal of Infectious and Endemic Diseases, 2, 2, 2012, 87-91. doi: 10.21608/aeji.2012.15955
Mahmod, A., Essa, S., Abdel Aal, E., Dawod, H. (2012). 'Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis', Afro-Egyptian Journal of Infectious and Endemic Diseases, 2(2), pp. 87-91. doi: 10.21608/aeji.2012.15955
Mahmod, A., Essa, S., Abdel Aal, E., Dawod, H. Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2012; 2(2): 87-91. doi: 10.21608/aeji.2012.15955
Evaluation of Carvedilol in Prevention of First Attack of Variceal Hemorrhage in Patients with Liver Cirrhosis
Tropical Medicine Department, Faculty of Medicine, Zagazig University, Egypt
Abstract
Background and study aim: Carvedilol has beneficial effects on splanchnic haemodynamics following acute and chronic administration in cirrhosis. The aim of this study is to evaluate the role of carvedilol in prevention of first variceal bleeding in patients with liver cirrhosis and to compare its effect with that of variceal band ligation (VBL) and propranolol. Patients and methods: Seventy five patients with liver cirrhosis and endoscopically proven esophageal varices (grade II or larger in size with or without variceal red color signs), that have not bled yet were randomized to either VBL performed every 2 weeks until varices were eradicated (25 patients), carvedilol 12.5mg once daily (25 patients) or propranolol titrated to reduce resting pulse by >25% (25 patients) and followed up on the same schedule at 6 and 12 months. Results: Carvedilol had lowest rate of the first variceal bleeding when compared with VBL and propranolol (10%, 12% and 20% respectively). Carvedilol had significantly decreased the percentage of patients with varices grade III or IV over the follow up period (from 40% to 24%). Both carvedilol and propranolol significantly decreased severity of portal hypertensive gastropathy over follow up period. On the other hand, VBL significantly increased severity of portal hypertensive gastropathy. Conclusion: Carvedilol is effective in preventing the first variceal bleeding. Carvedilol is an option for primary prophylaxis in cirrhosis and esophageal varices grade ≥ II in single daily dose of 12.5 mg.
Top